Search results
Results from the WOW.Com Content Network
Cerebral folate deficiency is a condition in which concentrations of 5-methyltetrahydrofolate are low in the brain as measured in the cerebral spinal fluid despite being normal in the blood. [3] Symptoms typically appear at about 5 to 24 months of age.
Signs of folate deficiency anemia most of the time are subtle. [4] Anemia (macrocytic, megaloblastic anemia) can be a sign of advanced folate deficiency in adults. [1] Folate deficiency anemia may result in feeling tired, weakness, changes to the color of the skin or hair, open sores on the mouth, shortness of breath, palpitations, lightheadedness, cold hands and feet, headaches, easy bleeding ...
Other common causes include diabetes, glandular fever, vitamin B12 and folate deficiency, and hypothyroidism, which is when the thyroid gland doesn’t produce enough thyroid hormone leading to ...
Folate in the form of folic acid is used to treat anemia caused by folate deficiency. [3] Folic acid is also used as a supplement by women during pregnancy to reduce the risk of neural tube defects (NTDs) in the baby. [3] [10] NTDs include anencephaly and spina bifida, among other defects.
“Eating a diet rich in the nutrients required to produce red blood cells can help alleviate symptoms of anemia, which includes iron, vitamin B12, and folate,” says Bloomberg. “Taking vitamin ...
There is risk that folic acid administered to those with B 12 deficiency may mask anemic symptoms without solving the issue at hand. In this case, people would still be at risk for neurological deficits associated with B 12 deficiency-related anemia, which are not associated with anemia related to folate deficiency. [30]
In fact, a severe deficiency in folate can result in a condition called folate-deficiency anemia which has symptoms like hair thinning and pigmentation changes in the hair.
A deficiency of folate itself does not cause neural tube defects. The association seen between reduced neural tube defects and folic acid supplementation is due to a gene-environment interaction such as vulnerability caused by the C677T methylenetetrahydrofolate reductase (MTHFR) variant.